emerging glp-1 gip weight loss treatments 2025 Therapy Part 1: Setting Realistic Expectations – Sarah Hormachea GLP-1 Pipeline Update: August 2025
Description
Suboptimal glycaemic control and increasing weight gainmajor risk factors for blood glucose and CV complicationsare key concerns for this patient
The ripple effects of GLP-1 therapies are poised to touch every corner of medicine
For example, the endoderm provides essential paracrine signals that influence cardiac specification and differentiation
Whats the difference between GLP-1 and dual agonists
Journal of the American Heart Association, 15, e047893
Lateral allosterism in the glucagon receptor family: Glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation
